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ABSTRACT  
Introduction: 
Use of intra-operative neuro-monitoring (IONM) during high-risk thyroidectomy has 
been suggested to decrease the rate of recurrent laryngeal nerve (RLN) palsy. 
However, current evidences were mixed and there was no large-scale study 
concluding its benefit. We evaluated the role of IONM in reducing RLN palsy during 
high-risk thyroidectomy and identified which high-risk subgroup would be most 
benefited. 
Methods: 
A systemic review was performed to identify studies comparing the use of IONM and 
visual identification of RLN alone (VA) during high-risk thyroidectomy, namely re-
operation, thyroidectomy for malignancy, thyrotoxicosis or retrosternal goitre. Rate of 
RLN palsy was presented in terms of number of nerve-at-risk (NAR). Meta-analysis 
on overall high-risk thyroidectomy and subgroups were performed using fixed or 
random-effects model.  
Results 
Ten articles were eligible for final analysis. There were 4460 NARs in VA group and 
6155 NARs in IONM group. Comparing to VA, IONM had lower rate of overall [4.5% 
vs. 2.5%, Odd ratio (OR): 1.40, 95% confidence interval (CI): 1.12 – 1.79, p=0.003] 
and temporary [3.9% vs. 2.4%; OR: 1.47, 95% CI: 1.07 – 2.00, p=0.016] RLN palsy 
in overall high-risk thyroidectomies. On subgroup analysis, although numbers of 
NARs were less than minimal numbers required for a statistical powered study (2.1% 
- 72.7%) , use of IONM decreased the rate of overall RLN palsy during re-operation 
(7.6% vs. 4.5%, OR: 1.32, p=0.021) and temporary RLN palsy during thyroidectomy 
for malignancy (3.1% vs. 1.6%, OR: 1.90, p=0.026). Use of IONM tended to have a 
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lower rate of overall RLN palsy during thyroidectomy for malignancy than VA alone. 
(3.5% vs. 2.1%, p = 0.050). 
Conclusions: 
Selective use of IONM during high-risk thyroidectomy decreased the rate of overall 
RLN palsy. IONM should be applied during re-operative thyroidectomy and 
thyroidectomy for malignancy.  
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INTRODUCTION 
Recurrent laryngeal nerve (RLN) palsy is one of the major morbidities after 
thyroidectomy. It results in hoarseness of voice, choking and aspiration in unilateral 
palsy. If both RLNs were paralysed, patients would suffer from potential fatal airway 
obstruction. RLN palsy not only affects quality of life, but also incurs more charges 
for health care.[1, 2] For thyroid surgeons, it is the major cause of litigation after 
thyroidectomy.[3] Technique of intra-operative neuro-monitoring (IONM) of RLN 
during thyroidectomy was first described in 1970s. IONM aids localisation of RLNs 
during thyroidectomy and facilitates identification of anatomical variation of RLN. It is 
believed that use of IONM can decrease the rate of RLN palsy. While post 
thyroidectomy RLN palsy is uncommon, ranged from 1.25% to 3.9%[4-6], previous 
studies have showed that routine application of IONM in all thyroidectomy did not 
decrease the rate of RLN palsy and it is not cost effective. Three meta-analysis with 
more than 3000 nerve-at-risks have failed to demonstrate any benefits in routine use 
of IONM during all thyroid surgeries. [7-9]  
On the other hand, use of IONM during high-risk thyroidectomy have been 
advocated. Re-operation, thyroidectomy for malignancy, thyrotoxicosis and 
retrosternal goitre were considered as high-risk thyroidectomy which the rate of RLN 
palsy were higher [10-14]. In re-operation thyroidectomy, presence of scar and 
anatomical distortion made routine dissection and identification of RLN difficult. The 
risk of RLN injuries were higher if surgeons fail to identify RLNs. [10] There were 4.6 
-10.4 times risk in having post-operative RLN palsy compared with primary operation 
[10, 13]. For thyroidectomy for malignancy, locally advance pathology and 
associated lymph node dissection added the risk to RLN palsy. [15] Comparing to 
thyroidectomy for benign goitre, operation for malignancy had a relative risk of 2.0 - 
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5.4 in developing RLN palsy [10, 13]. In view of high incidence of RLN palsy and 
needs of RLN localisation, selective use of IONM during high-risk thyroidectomy is 
suggested [16]. Some studies have showed that use of IONM during thyroidectomy 
for recurrent goitre or malignancy decreased the rate of RLN palsy. [17-20] However, 
other studies reported that there was no significant improvement if IONM was 
applied. [10, 21-24] Due to relatively small sample size, power and their conclusion 
have been questioned. In this study, we aimed to evaluate the role of IONM in 
decreasing RLN palsy during high-risk thyroidectomy. We performed a subgroup 
analysis and evaluated which high-risk subgroup would be most benefited in using 
IONM.   
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METHODS: 
This systemic review and meta-analysis were conducted in accordance with the 
PRISMA statement. [25]  
Search Strategy 
Studies comparing RLN palsies between use of IONM and visualization of RLN 
alone (VA) during thyroidectomy were retrieved from Pubmed, Medline, Embase and 
Cochrane central register of clinical trials (CENTRAL) on 18th September 2015. We 
used the following free text search terms in “All fields”.  
#1: “Thyroid Surgery “ OR “ Thyroidectomy” 
#2: “Intra-operative neuro-monitoring” OR “Recurrent laryngeal nerve monitoring” 
#3: “High risk” OR “Re-operation” OR “cancer” OR “carcinoma” OR “thyrotoxicosis” 
OR “Toxic goitre” OR “retrosternal” OR “substernal” 
We used a combination of #1, #2 and #3 in literature search. There was no language 
restriction or methodological filters. Studies published dated from 1st January 2000 
to 30th June 2015 were included. The bibliographies of five previous meta-analysis 
were reviewed and looked for relevant references. [7, 9, 26-28] 
Study selection   
All titles identified were screened independently by two authors (K.P.W. & K.L.M.). 
Results were compared and any disagreements were resolved by consensus. 
Abstract of any potential articles were reviewed, eligible studies were selected for full 
article review. 
Studies were included in the meta-analysis if they met the following criteria.  
1. Full English-language article on human patients.  
2. Any randomized control trial, prospective or retrospective comparative studies 
comparing the rate of RLN palsy between thyroidectomy with VA and IONM. 
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3. Thyroidectomy in patients with history of thyroid surgery, thyroidectomy for 
thyroid cancer, thyrotoxicosis or retrosternal goitre 
4. Data on number of RLN at risk and RLN palsy that could be extracted from 
published manuscript for calculation. 
5. Number of post-operative RLN palsy was determined by laryngoscopy. 
Case reports, editorials, expert opinions and reviews without original data were 
excluded. In case of potential duplicate data from same authors and center, studies 
with most representable data were selected for analysis.  Newcastle-Ottawa Scale 
(NOS) assessed quality of study. 
Data extraction   
All data were extracted onto a standardized form.  Primary data included type or 
design of study, first authorship, country of origin, year of publication, patient 
demographics, history of previous thyroidectomy, presence of thyroid cancer, 
thyrotoxicosis, retrosternal goitre, neuro-monitoring machine, electrode applied, 
stimulation current applied, site of nerve stimulation, extent of thyroidectomy, number 
of patients, number of RLN at risk, definition and number of temporary and 
permanent RLN palsy. Rate of RLN palsy was calculated with the total number of 
nerves-at-risk (NARs) as the denominator. Temporary and permanent RLN palsy 
was defined according to definition of the original article, and overall RLN palsy was 
the sum of temporary and permanent palsy. Data were also stratified into four 
subgroups, namely re-operation (thyroidectomy was preformed in patients with 
history of previous neck operation), malignancy (thyroidectomy was preformed for 
malignant thyroid cancer), thyrotoxicosis and retrosternal goitre for sub-group 
analysis. 
Statistical analysis  
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All individual outcomes were integrated with the meta-analysis software Review 
Manager Software 5.0 (Cochrane Collaborative, Oxford, England). Odd ratios (OR) 
were calculated for rate of RLN palsy. Heterogeneity was assessed with I2 test by 
both fixed and random-effects model.[29] Any I2 test > 50% was considered 
substantial heterogeneity. Fixed-effect models were used for analysis. If I2 test for 
fixed-effect models > 50%, random-effects model were applied. Publication bias was 
assessed using Begg’s rank correlation test and Egger’s regression test. Analysis 
was performed in overall patients and aforementioned four subgroups. The statistical 
analysis was performed using the IBM SPSS version 20.0 (IBM, Armonk, NY) and 
Comprehensive Meta-Analysis Version 2.2.064 (Biostat, Inc., Englewood, NJ). P-
value < 0.05 was considered as statically significant.  
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RESULTS 
Figure 1 shows the PRISMA flowchart of article selection. After initial search, 249 
articles were identified and 10 articles were retrieved from five other meta-analysis 
[7, 9, 26-28]. 75 articles were found to be duplicated and thus excluded. After 
screening title, 42 non-English and 92 irrelevant articles were excluded. On 
screening abstract of 50 articles, 28 articles were excluded, as they did not fulfil the 
selection criteria. 22 articles remained and were assessed in full-text. Among them, 
12 articles were further excluded, in which 4 articles had data presented later in a 
more representative article [12, 30-32], 3 articles were not assessing RLN palsy in 
high-risk thyroidectomy [33-35],  no data can be extracted in 3 articles [11, 36, 37]  
and no full manuscript was available in 1 article [38]. One study which laryngoscopy 
was not routinely performed was also excluded [19]. Therefore, ten studies were 
included for final analysis. 
Study Characteristics  
Table 1 shows the study design, distribution of high-risk subgroups, quality of study 
and number of nerve-at-risk in ten included studies. Two prospective comparative 
studies and eight retrospective studies were included. The comparison of 
thyroidectomy with VA against IONM in “re-operation”, “malignancy”, “thyrotoxicosis” 
and “retrosternal goitre” subgroups were reported in 7, 6, 4, 2 articles respectively. 
Data were extracted for pooling and analysis. However, Atallah et al did not report 
the rate of RLN palsy of each subgroup [22]. Therefore, its data was not included for 
subgroup analysis. According to data pooling from 10 studies, there were 4460 
NARs in VA group, and 6155 NARs in IONM group.  
Comparing between VA and IONM group, there were no difference on baseline 
demographic and clinic-pathological data in six articles. Comparing to VA group, 
1
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three studies have shown that duration of operation with IONM was longer [21, 23, 
39]. In contrast, despite more bilateral thyroidectomy were performed in IONM group, 
Barczynski et al reported that use of IONM had a shorter duration of operation in a 
study on re-operative thyroidectomy[20]. (94.5+/- 23.0 mins. vs. 88.3 +/- 23.3 mins, 
p<0.001)  
Table 2 shows timing of initial post-operative laryngoscopic assessment, definition of 
permanent recurrent laryngeal nerve palsy, set-up and application of intra-operative 
neuro-monitoring (IONM). Routine pre-operative laryngoscopies were performed in 
all studies. For post-operative laryngoscopy, all studies performed post-operative 
laryngoscopic examination to evaluate vocal cord function from immediate after 
operation to within 2 weeks after operation. Permanent RLN palsy was defined as 
RLN palsy that did not recover within 12 months in 6 studies and 6 months in 2 
studies.  On the other hand, temporary RLN palsy was defined as recovery of RLN 
function within 12 months in 6 months and 6 months in 2 studies. In the study by 
Prokopakis et al, all patients with RLN palsy recovered by 4 months [39]. 
For IONM, insertion of needle electrodes into vocal cord was reported in 5 studies, 
which all of them were at the early phase of studies [10, 18, 20, 22, 23]. Surface 
electrode integrated into endotracheal (ET) tube was used in 7 studies.  Electrodes 
were connected to Neurosign 100 system (Magstim Clarify Company, Whitland, UK) 
in 5 studies, and NIMS response 2.0 or 3.0 Nerve monitoring systems (Medtronic, 
Jacksonville, FL, US) in 7 studies. Stimulation current ranged from 0.05 to 5 mA. 
Pre-dissection vagal stimulations as suggested by guideline from International 
Neural Monitoring Study Group (INMSG) were performed in 4 studies [40]. Both 
direct (RLN) and indirect (vagus) nerve stimulation were applied in 7 studies.  
Analysis on heterogeneity 
1
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Heterogeneity was observed in temporary RLN palsy in “re-operation” subgroup (I2: 
63.0%) and overall RLN palsy in “thyrotoxicosis” subgroup (I2: 51.3%). Therefore, we 
adopted random-effect models in these subgroup analyses. 
Overall high-risk thyroidectomy 
Results from 10 studies were pooled up. There were 4460 NARs in VA group, and 
6155 NARs in IONM group. Rate of overall [4.5%, (201/4460) vs. 2.5% (151/6155), 
Odd ratio (OR): 1.42, 95% confidence interval (CI): 1.12 – 1.79, p=0.003] and 
temporary [3.9% (129/3332) vs. 2.4% (71/3017); OR: 1.47, 95% CI: 1.07 – 2.00, 
p=0.016] RLN palsy were higher in VA group than IONM group. (Figure 2) 
Permanent RLN palsy was comparable between two groups. [1.6% vs. 1.3%, OR: 
1.33, 95% CI: 0.94 - 1.88, p=0.104]  No publication bias was found by Begg analysis 
and Egger regression test on meta-analysis. (P > 0.05) 
Re-operation 
In seven included studies, three of them clearly stated that RLNs were at risk in a 
previously operated field [20, 23, 39], while others did not describe whether the NAR 
was at the previously explored side or the contra-lateral side [10, 16, 21, 41]. 
Barczynski et al reported that IONM had a lower rate of overall (4.0% vs. 8.7%, 
p=0.001) and temporary (6.3% vs. 2.6%, p=0.003) RLN palsy than VA.14 On meta-
analysis, the rate of overall RLN palsy [7.6% (114/1497) vs. 4.5% (78/1751), OR: 
1.48, 95% CI: 1.06 - 2.06, p=0.021] is lower in IONM group than VA group. (Figure 
3) Permanent (2.7% vs. 2.5%; OR: 1.40, 95% CI: 0.98 to 2.47, p=0.171) and 
temporary RLN palsy (6.3% vs. 4.3%, OR: 1.24, 95% CI: 0.52 to 2.97, p= 0.631) 
were comparable. No publication bias was found. (P > 0.05) 
Malignancy 
1
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Data from five articles were pooled for analysis. The rate of temporary RLN palsy 
was significantly higher in VA group than in IONM group [3.1% (36/1160) vs. 1.6% 
(21/1282), OR: 1.90, 95% CI: 1.08 to 3.35, p=0.026].  However, the rate of overall 
RLN palsy (3.5% vs. 2.1%, OR: 1.52, 95% CI: 0.98 to 2.36, p=0.050) and permanent 
RLN palsy (3.1% vs. 1.6%, OR: 1.1, 95% CI: 0.61 to 2.11, p=0.696) were 
comparable. (Figure 4) Publication bias was noted at analysis on permanent RLN 
palsy by Egger Regression test (t-value = 3.956, p= 0.029). 
Thyrotoxicosis  
Pooled data of three articles showed 1166 NARs in VA group and 1836 NARs in 
IONM group [12, 16, 41]. The rate of overall RLN palsy (1.1% vs. 0.7%, OR: 1.33, 
95% CI: 0.41 to 4.36, p=0.640), permanent (0.6% vs. 0.2%, OR: 3.57, 95% CI: 1.00 
to 12.76, p=0.051) and temporary RLN palsy (0.8% vs. 1.2%, OR: 0.60, 95% CI: 
0.21 to 1.71, p= 0.338) were not significantly different. No publication bias was 
found. (P > 0.05) 
Retrosternal goitre  
Only one study by Chan et al reported the rate of RLN palsy in thyroidectomy for 
retrosternal goitre [16]. Rate of overall (7.7% vs. 3.4%, p=0.317), temporary (7.7% 
vs. 1.7%, p=0.128) and permanent RLN palsy (0% vs. 1.7%, p=0.346) were 
comparable between VA group and IONM group.  
1
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DISCUSSION 
Two previous meta-analysis reviewing the role of rountine IONM in all thyroidectomy 
have performed subgroup analysis on high-risk thyroidectomy. Higgins et al defined 
re-operation and thyroidectomy for malignancies, thyrotoxicosis or retrosternal goitre 
as high-risk thyroidectomy. They found that there were no benefits in using IONM in  
high-risk thyroidectomies [7]. However, it has been criticized for inclusion of non-
comparative studies and case reports in the study. Pisanu et al reported another 
meta-analysis and showed similar findings [9]. With IONM, overall, temporary and 
permanent RLN palsy were comparable to thyroidectomy without IONM. To report a 
statistically representative study evaluating the role of IONM, around 9000 NARs 
were required [11]. However, the sample size in meta-analysis by Pisanu et al 
(around 3300 NARs) was much lower than suggested. Therefore, non-beneficence 
in using IONM during high-risk thyroidectomy cannot be concluded. To our 
knowledge, our study is the first meta-analysis focusing on the use of IONM in high-
risk thyroidectomy. We also evaluated which subgroup of high-risk thyroidectomy 
would be benefited. We have applied stringent selection criteria and included up-to-
date publications. Total number of nerve-at-risk included was about 10500. We 
believed that this meta-analysis is a statistically powered study to evaluate whether 
IOMN should be used during high-risk thyroidectomies. 
From our results, applications of IONM can lower the overall and temporary RLN 
palsy during high-risk thyroidectomy. Although the number of NARs in this meta-
analysis was less than the minimal number of NARs required, we still demonstrated 
statistically significant improvement of overall and temporary RLN palsy with the use 
of IONM. (Table 3) Therefore, we recommended routine use of IONM during high-
risk thyroidectomies.  
1
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There was a strong debate on whether IONM is beneficial during re-operation in 
recent literatures [19, 20, 23, 39]. In subgroup analysis, we cannot demonstrate any 
benefits in either permanent or temporary RLN palsy. For a sufficiently powered 
comparison, 4744 and 7561 NARs were required for permanent and temporary RLN 
palsy respectively. (Table 3) However, there were only 10.7-35.6% of the required 
NARs available for meta-analysis. As this subgroup analysis is considered 
underpowered due to small sample size, we cannot deny or support the positive role 
of IONM in terms of temporary or permanent RLN palsy. However, we confirmed that 
applications of IONM decreased overall RLN palsy. (OR: 1.32, p = 0.021). It could be 
due to relative higher sample size to achieve a statistically significant result. (35.7% - 
41.7%) On the other hand, half of the studies did not state whether re-operation was 
performed on the previously explored side [10, 16, 21, 41]. These results might 
overlook the benefit of IONM. Therefore, the result should be interpreted cautiously. 
Future prospective controlled studies focusing on re-operation in a previously 
operated field would be worthwhile in evaluating the benefit of IONM.  
For thyroidectomy on malignancy, although the rate of permanent RLN palsy did not 
decrease if IONM was used, there was publication bias observed in this analysis. 
Despite insignificance of odds ratio (p-value = 0.696), we should be cautious with the 
pooled estimates of permanent RLN palsy in this subgroup analysis. In view of 
benefits on temporary and potential overall RLN palsy, routine use of IONM during 
thyroidectomy for malignancy should also be supported. For toxic goitre, rate of RLN 
palsy was 0.8% in pooled data of 3 included studies. To demonstrate its benefit on 
overall RLN palsy, 26000 NARs for each group were needed. (Table 3) A study to 
evaluate the benefits of IONM in this group might not be practical and worthwhile.  
1
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We realized that there were some drawbacks in our analysis. As majority of the 
studies were retrospective & observational, they were prone to be difficult in 
interpretation with bias. Therefore, the findings were weaker than a meta-analysis 
including prospective randomized controlled trials (RCT). However, to our 
knowledge, there were no prospective RCTs focusing on high-risk thyroidectomy 
available in the literature. Secondly, there were large heterogeneities between 
studies. This was related to diversity in patients recruited, operative techniques and 
the way IONM applied. Bias in patients’ allocation was also present. It reflected by 
the fact that more extensive surgery (in term of bilateral surgery and total 
thyroidectomy) was performed in IONM group [20, 21, 23], and IONM was more 
likely to be used in later part of the study [17, 18, 20, 21]. Although guideline on 
IONM by INMSG that aimed to standardize the technique was published in 2011, 
most patients in this study were recruited before that. Algorithm of IONM including 
pre-dissection vagal stimulation and site of nerve stimulation varied in different 
centers. All these factors led to a large heterogeneity in the analysis. By analyzing 
the results with random-effect model, we minimized the effect of heterogeneity on 
our results.  
In this meta-analysis, all included studies evaluated the use of intermittent IONM. 
There was a risk of RLN injury before identification or in-between nerve stimulations 
[42]. Nowadays, continuous neuro-monitoring of RLN have gained increasing 
interests as it provides a real-time feedback to surgeons to avoid RLN injuries. 
Further studies are needed to evaluate whether continuous neuro-monitoring 
provides superior protective effect to intermittent IONM or visual identification of RLN 
alone in the high-risk thyroidectomy. 
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CONCLUSON  
Routine identification of RLN remains the key to avoid vocal cord palsy and it is 
necessary for intermittent nerve stimulations during conventional IONM. Selective 
use of IONM during high-risk thyroidectomy decreases the rate of RLN palsy and 
should be recommended during re-operation or thyroidectomy for malignancy. 
1
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Legend: 
Fig. 1 PRISMA Flowchart of article selection 
Fig. 2 Forest plot showing the rate of (A) overall, (B) permanent and (C) temporary 
recurrent laryngeal nerve palsy in visualization alone (VA) group and intra-operative 
neuro-monitoring (IONM) group during overall high risk thyroidectomy. 
Abbreviation: VA = visualization alone; IONM = intra-operative neuro-monitoring; 
RLN = recurrent laryngeal nerve 
Fig. 3 Forest plot showing the rate of (A) overall, (B) permanent and (C) temporary 
recurrent laryngeal nerve palsy in visualization alone (VA) group and intra-operative 
neuro-monitoring (IONM) group during re-operation thyroidectomy 
Abbreviation: VA = visualization alone; IONM = intra-operative neuro-monitoring; 
RLN = recurrent laryngeal nerve 
Fig. 4 Forest plot showing the rate of (A) overall, (B) permanent and (C) temporary 
recurrent laryngeal nerve palsy in visualization alone (VA) group and intra-operative 
neuro-monitoring (IONM) group during thyroidectomy for malignancy 
Abbreviation: VA = visualization alone; IONM = intra-operative neuro-monitoring; 
RLN = recurrent laryngeal nerve 
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List of table. 
Table 1. Study design, distribution of high-risk subgroups, quality of study and 
number of nerve-at-risk in ten included studies.  
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permanent recurrent laryngeal nerve palsy and set-up of intra-operative neuro-
monitoring (IONM). 
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operative neuro-monitoring (IONM group). 
 19 
Table 1. Comparison of study design, distribution of high-risk subgroup, quality of study and number of nerves-at-risk in ten 
included studies. 
Abbreviation: NOS Scale = Newcastle-Ottawa Scale, PCS = Prospective comparative study; RS = Retrospective comparative 
study; MC = multi-center study; VA = visualization of recurrent laryngeal nerve alone, IONM = intra-operative neuro-monitoring 
  
Author Year Country 
Type of 
study 
High risk subgroup NOS Nerves at risk 
Re-
operation 
Mali-
gnancy 
Thyro-
toxicosis  
Retro-
sternal Selection Comparability Outcome VA IONM 
Dralle6  2004 Germany PCS, MC √ √ √  **** * ** 1128 3138 
Yarbrough21 2004 United States RS √    ***  * 79 72 
Chan16 2006 Hong Kong PCS √ √ √ √ **** * ** 293 301 
Atallah22 2009 France RS √ √ √ √ ** * ** 240 181 
Frattini17  2010 Italy RS  √   *** * *** 152 152 
Barczynski18  2011 Poland RS  √   ** * *** 302 302 
Alesina17 2012 Germany RS √    *** * ** 161 128 
Alesina23 2013 Greece  RS √    *** *  61 60 
Barczynski14 2014 Poland RS √    *** * ** 826 500 
Prokopakis24 2014 Italy RS  √ √  **** * * 1218 1321 
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Table 2. Initial post-operative laryngoscopic assessment, definition of permanent recurrent laryngeal nerve palsy, set-up and 
application of intra-operative neuro-monitoring (IONM).  
Author 
Initial post-operative 
assessment Definition of permanent 
palsy 
IONM Set-up Application of IONM 
Timing Method Electrode Machine Stimulation Site of stimulation Pre-dissection vagal stimulation 
Dralle6  - Laryngoscopy 6 months NE Neurosign 100 0.05-5mA RLN - 
Yarbrough21 - IL / FL -  NE - -  RLN, vagus - 
Chan16 < 2 weeks IL / FL 12 months SE Neurosign 100 0.5-1.5mA RLN - 
Atallah22 < 1 week  DL / FL  12 months SE NIMS 2.0 0.4-1.5mA RLN, vagus - 
Frattini17  1-2 days Laryngoscopy 12 months - NIMS 2.0 0.5-3 mA RLN, vagus Yes 
Barczynski18  At the end of operation RL 12 months 
NE Neurosign 100 1mA RLN, vagus Yes SE NIMS 2.0 1mA 
Alesina23 1 day DL 6 months Before 2009, NE Neurosign  - RLN, vagus - After 2010, SE NIMS 3.0 0.5-1.0mA 
Prokopakis24 - FL # SE NIMS 0.5mA RLN - 
Barczynski20 1 day IL / DL  12 months In 2004-2007, NE Neurosign 100 1mA RLN, vagus Yes In 2008-2012, SE NIMS 2.0/3.0 1mA 
Calo32 2 day Laryngoscopy 12 months SE NIMS 2.0/3.0  - RLN, vagus Yes 
 
Abbreviation: RLN = recurrent laryngeal nerve; RL = rigid laryngoscopy; DL = direct laryngoscopy; IL = indirect laryngoscopy; FL = 
flexible laryngoscopy; IONM = intra-operative neuro-monitoring; SE = surface electrode at endotracheal tube; NE = needle 
electrode 
# - All patients with RLN palsy recovered within 4 months 
2
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Table 3. Power calculation of minimal number of nerves-at-risk (NARs) to 
demonstrate significant difference between visualization alone (VA group) and intra-
operative neuro-monitoring (IONM group). 
Abbreviation:  
NAR = nerve-at-risk, VA = visualization alone; IONM = intra-operative neuro-
monitoring; RLN = recurrent laryngeal nerve; OR = odd ratio 
* - p-value < 0.05; ^ - p-value = 0.050; ^^ - p-value = 0.051 
 
 
 Rate of RLN palsy Minimal number 
of NARs for each 
group 
NARs in this study 
 VA IONM OR VA IONM 
Overall high risk 
Overall palsy 4.5% 2.5% 1.40* 4962 4460 (89.9%) 6155 (124.0%) 
Permanent 
palsy 1.6% 1.3% 1.33 12960 4399 (33.9%) 6095 (47.0%) 
Temporary 
palsy  3.9% 2.4% 1.47* 4711 3332 (70.7%) 3017 (64.0%) 
Re-operation 
Overall palsy 7.6% 4.5% 1.32* 4196 1497 (35.7%) 1751 (41.7%) 
Permanent 
palsy 2.7% 2.5% 1.40 4744 1436 (30.6%) 1691 (35.6%) 
Temporary 
palsy  6.3% 4.3% 1.24 7561 1188 (15.7%) 812 (10.7%) 
Malignancy 
Overall palsy 3.5% 2.1% 1.52^ 3552 1596 (44.9%) 2468 (69.5%) 
Permanent 
palsy 1.2% 1.3% 1.13 77499 1596 (2.1%) 2468 (3.2%) 
Temporary 
palsy 3.1% 1.6% 1.90* 1764 1160 (65.8%) 1282 (72.7%) 
Thyrotoxicosis 
Overall palsy 1.1% 0.65% 1.33 26190 1166 (4.5%) 1836  (7.0%) 
Permanent 
palsy 0.6% 0.2% 3.56^^ 3353 1166 (34.8%) 1836 (54.8%) 
Temporary 
palsy  0.8% 1.2% 0.60 48103 751 (1.6%) 727 (1.5%) 
2
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